Traveler’s Diarrhea Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
The traveler’s diarrhea treatment market is expected to witness a robust growth due to surge in the number of travelers, rising awareness among travelers and availability of over the counter medications. Traveler’s diarrhea affects millions of international travelers, who travels to developing countries each year. Food and contaminated water are the main sources of infection. Bacteria such as E. coli, and Salmonella are common causes of traveler’s diarrhea. According to World Tourism Organization (UNWTO), in 2019, around 1.5 billion international tourist arrivals were recorded, a 4% rise from 2018. The prevalence of traveler’s diarrhea is higher among travelers visiting regions in South Asia and Southeast Asia. Travel destination is the most significant risk factor for traveler’s diarrhea. Hence, owing to these factors, the market will witness significant growth in the forecast period. However, the side effects associated with the drugs are expected to impede the market growth.
Key Market Trends
Retail Pharmacies Segment is Expected to Show Better Growth in the Forecast Years
Based on Distribution Channel, the market is segmented into hospital pharmacies, retail pharmacies and other distribution channels. A retail pharmacy refers to the independent pharmacy, which is having a state license to dispense medications to the general public. The people are increasingly adopting retail pharmacy as a one-stop shop to buy medicines. These are highly preferred by people who are unable to reach hospitals for check up on the regular basis and need medicine for quick treatment. The better outreach of retails pharmacies makes it a highly profitable segment and most established across several countries. Furthermore, the surge in the number of travelers is also expected to fuel the market growth in the forecast period.
North America holds the Largest Share in the Traveler’s Diarrhea Treatment Market
The traveler’s diarrhea treatment market holds the largest share in the North America region due to increasing burden of travelers diarrhea and strong presence of manufacturers in this region. The rising awareness, along with easy availability of over the counter medications is likely to favor the growth of the traveler’s diarrhea treatment market in North America. However, the side effects associated with the drugs are likely to impede the growth of the studied market in the forecast period.
The market studied is moderately competitive and there are several global companies that are operating in this market. The major players into the traveler’s diarrhea treatment market are Bausch Health Companies Inc. (Salix Pharmaceuticals), Bristol-Myers Squibb Company, Cosmo Pharmaceuticals N.V., Immuron Limited, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Sanofi S.A. and Valneva Canada Inc.
Reasons to Purchase this report:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook